Top Clinical Trials companies in France by EBIT Margin
France
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
16.18%
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
|
| 2 |
-24.41%
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
| 3 |
-54.30%
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
| 4 |
-83.63%
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
| 5 |
-93.61%
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
| 6 |
-105.12%
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
| 7 |
-151.00%
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
| 8 |
-170.22%
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
| 9 |
-205.08%
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
| 10 |
-240.83%
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
| 11 |
-527.02%
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
| 12 |
-598.32%
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
| 13 |
-923.35%
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
| 14 |
-925.09%
|
Dec. 31, 2023 | USD 7.66 | 0.25% |
|
France |
|
| 15 |
-944.14%
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
| 16 |
-1,058.87%
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
| 17 |
-1,208.10%
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
|
| 18 |
-1,258.01%
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
|
| 19 |
-2,897.94%
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
| 20 |
-8,137.93%
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
Frequently Asked Questions
-
Which Clinical Trials company in France has the highest EBIT Margin ?
The Clinical Trials company in France with the highest EBIT Margin is Eurofins-Cerep SA (Paris Stock Exchange: ALECR.PA) at 16.18%.
-
Which Clinical Trials company in France has the lowest EBIT Margin ?
The Clinical Trials company in France with the lowest EBIT Margin is Crossject SA (Paris Stock Exchange: ALCJ.PA) at -8,137.93%.
-
What are the top 10 Clinical Trials companies in France by EBIT Margin ?
The top 10 Clinical Trials companies in France by EBIT Margin are Eurofins-Cerep SA, Innate Pharma S.A., Aelis Farma SA, Genfit S.A., Median Technologies SA, Nanobiotix S.A., Valbiotis SA, MedinCell S.A., Advicenne S.A. and Novacyt S.A..
-
What are the bottom 10 Clinical Trials companies in France by EBIT Margin ?
The bottom 10 Clinical Trials companies in France by EBIT Margin are Crossject SA, ABIVAX SA, Affluent Medical SA, Predilife S.A., AB Science S.A., OSE Immunotherapeutics SA, MaaT Pharma SA, Adocia SA, Inventiva S.A. and DBV Technologies S.A..
